Evidence map›Paper›PMID 26936712›Full record

ArticleMedical physics2016

Tumor radio-sensitivity assessment by means of volume data and magnetic resonance indices measured on prostate tumor bearing rats.

Antonella Belfatto, Derek A White, Ralph P Mason, Zhang Zhang, Strahinja Stojadinovic, Guido Baroni, Pietro Cerveri

Open access · hybridAbstract read
In one paragraph

Article in Medical physics, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.2field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 9 citations in OpenAlex.

  1. Observational
  2. TThe British journal of radiology · 2023
    Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 2 countries.

Antonella BelfattoDepartment of Electronics, Information and Bioengineering, Politecnico di Milano University, Milan 20133, Italy.
Derek A WhiteDepartment of Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Ralph P MasonDepartment of Radiology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Zhang ZhangDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Strahinja StojadinovicDepartment of Radiation Oncology, The University of Texas Southwestern Medical Center, Dallas, Texas 75390.
Guido BaroniDepartment of Electronics, Information and Bioengineering, Politecnico di Milano University, Milan 20133, Italy.
Pietro CerveriDepartment of Electronics, Information and Bioengineering, Politecnico di Milano University, Milan 20133, Italy.
The University of Texas Southwestern Medical Center · USPolitecnico di Milano · IT

Funding

UT Southwestern Medical Center Simmons Comprehensive Cancer CenterP30CA142543 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI Sandi Leigh Pruitt · 2010 to 2026
$53.7M
TR&D 3: Imaging Carbohydrate MetabolismP41EB015908 · NIBIB · UT SOUTHWESTERN MEDICAL CENTER · PI MALLOY, CRAIG R · 2012 to 2021
$10.9M
Hypoxia and Radiotherapy: Evaluation and Mitigation in TumorsR01CA139043 · NCI · UT SOUTHWESTERN MEDICAL CENTER · PI MASON, RALPH P. · 2010 to 2014
$1.6M
X-RAD 225Cx Image Guided Biological Irradiator SystemS10RR028011 · NCRR · UT SOUTHWESTERN MEDICAL CENTER · PI SOLBERG, TIMOTHY · 2010 to 2010
$490k
NCI NIH HHS 5R01 CA139043NCI NIH HHS P30 CA142543NCI NIH HHS R01 CA139043NCRR NIH HHS S10 RR028011NIBIB NIH HHS 1P30 EB015908NIBIB NIH HHS EB015908NIBIB NIH HHS P41 EB015908
6 · The paper itself

Abstract

purposeRadiation therapy is one of the most common treatments in the fight against prostate cancer, since it is used to control the tumor (early stages), to slow its progression, and even to control pain (metastasis). Although many factors (e.g., tumor oxygenation) are known to influence treatment efficacy, radiotherapy doses and fractionation schedules are often prescribed according to the principle "one-fits-all," with little personalization. Therefore, the authors aim at predicting the outcome of radiation therapy a priori starting from morphologic and functional information to move a step forward in the treatment customization.

methodsThe authors propose a two-step protocol to predict the effects of radiation therapy on individual basis. First, one macroscopic mathematical model of tumor evolution was trained on tumor volume progression, measured by caliper, of eighteen Dunning R3327-AT1 bearing rats. Nine rats inhaled 100% O2 during irradiation (oxy), while the others were allowed to breathe air. Second, a supervised learning of the weight and biases of two feedforward neural networks was performed to predict the radio-sensitivity (target) from the initial volume and oxygenation-related information (inputs) for each rat group (air and oxygen breathing). To this purpose, four MRI-based indices related to blood and tissue oxygenation were computed, namely, the variation of signal intensity ΔSI in interleaved blood oxygen level dependent and tissue oxygen level dependent (IBT) sequences as well as changes in longitudinal ΔR1 and transverse ΔR2(*) relaxation rates.

resultsAn inverse correlation of the radio-sensitivity parameter, assessed by the model, was found with respect the ΔR2(*) (-0.65) for the oxy group. A further subdivision according to positive and negative values of ΔR2(*) showed a larger average radio-sensitivity for the oxy rats with ΔR2(*)<0 and a significant difference in the two distributions (p < 0.05). Finally, a leave-one-out procedure yielded a radio-sensitivity error lower than 20% in both neural networks.

conclusionsWhile preliminary, these specific results suggest that subjects affected by the same pathology can benefit differently from the same irradiation modalities and support the usefulness of IBT in discriminating between different responses.

Indexed as

Magnetic Resonance ImagingRadiation ToleranceTumor BurdenAnimalsDose Fractionation, RadiationMaleModels, BiologicalNeural Networks, ComputerOxygenProstatic NeoplasmsRatsOxygen

Identifiers

PMID26936712
PMCPMC5148178
OpenAlexW2271911140

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.